A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

Rendering a drug effective or ineffective in a flash at the appropriate location—this is the focus of research in photopharmacology. The goal is to develop drugs that can be switched on and off with ...

Imagine you're about to give a presentation to a room full of people.

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...

Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...

Beta-blocker use by men with high-risk or metastatic prostate cancer (PCa) is associated with a decreased risk of PCa-specific mortality, a new study suggests. The study, led by Kristin Austlid Taskén ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...